Since last fall, the synthetic opioids have appeared mostly in the South and Midwest and evade standard toxicology tests.
Researchers say orphines are about 10 times stronger than fentanyl, can cause rapid fatal respiratory collapse, and may require many naloxone doses to reverse overdoses.
Developed in the 1960s alongside fentanyl, they were abandoned after severe side effects and addiction risks; health and law enforcement officials are now assessing the threat.
As banning one drug unleashes a deadlier one, is the current strategy against synthetic opioids destined to fail?
How can communities defend against a new opioid that is ten times deadlier than fentanyl and invisible to standard tests?
Cychlorphine Overdose Outbreak in East Tennessee: 41 Deaths and the Rising Threat of Ultra-Potent Synthetic Opioids (2025-2026)
Overview
Cychlorphine, a synthetic opioid ten times stronger than fentanyl, emerged in the United States in late 2025, causing at least 41 overdose deaths in Tennessee by early 2026, with East Tennessee as the epicenter due to advanced local testing. Many states lack the ability to detect cychlorphine, leading to underreporting and delayed national recognition. Its extreme potency and resistance to standard naloxone reversal make overdoses especially deadly, often complicated by mixtures with other drugs. Despite a national decline in overdose deaths, cychlorphine threatens to worsen existing disparities and could reverse progress without improved detection, higher naloxone doses, and targeted public health responses.